Trials / Terminated
TerminatedNCT02093468
Evaluation of MST-188 in Acute Lower Limb Ischemia
Evaluation of MST-188 in Acute Lower Limb Ischemia: A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multi-Center Clinical Trial Evaluating the Safety and Efficacy of MST-188 in Subjects With Acute Lower Limb Ischemia Receiving Catheter-Directed Recombinant Tissue Plasminogen Activator
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Mast Therapeutics, Inc. · Industry
- Sex
- All
- Age
- 30 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of MST-188 in subjects receiving catheter-directed rt-PA for acute lower limb ischemia and to evaluate whether treatment with MST-188 results in more rapid thrombolysis of the occlusion and more rapid tissue perfusion in the effected blood vessel.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | MST-188 | |
| DRUG | Saline |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2016-12-01
- First posted
- 2014-03-21
- Last updated
- 2015-12-15
Locations
4 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02093468. Inclusion in this directory is not an endorsement.